Patent · US Active

Compounds and method for treating dyslipidemia

US7786108B2 · kind B2 · utility

2Cited by
6References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2005
Grant dateAug 31, 2010
Priority date
Expiry dateMay 17, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of formula Iwherein n, m, p, q, Y, R1 R2, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.